Don't let Ab­b­Vie fool FTC with an easy di­vesti­ture, plead crit­ics in lat­est at­tack on $63B Al­ler­gan buy­out

If the FTC must let Ab­b­Vie and Al­ler­gan go ahead with their merg­er, at least make them di­vest their lat­est block­buster on the mar­ket, a cho­rus of unions, con­sumer groups and pub­lic in­ter­est or­ga­ni­za­tions plead in a new at­tempt to rein in the megamerg­er.

There’s a sec­ond part to their ar­gu­ment: If the an­titrust watch­dog does green­light the di­vesti­ture Ab­b­Vie wants, then at least en­sure the phar­ma gi­ant can­not cor­ner its fu­ture ri­vals with its ex­clu­sion­ary tac­tics.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER